ARS Pharmaceuticals, Inc. SPRY Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about ARS Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ARS Pharmaceuticals, Inc.'s shares (diluted)?
- ARS Pharmaceuticals, Inc. (SPRY) reported shares (diluted) of 99.3M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- ARS Pharmaceuticals, Inc.'s shares (diluted) increased by 1.3% year-over-year, from 98.1M to 99.3M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), ARS Pharmaceuticals, Inc.'s shares (diluted) has grown at a 31.0% compound annual growth rate (CAGR), from 133.5M to 393.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.